Press Releases

Creative Enzymes Announces the Launch of Kex2 Protease from Saccharomyces Cerevisiae, Recombinant

Creative Proteomics Cytokine Accelerates Your Project with Its Colony Stimulating Factor Detection Service

Pronalyse Unveils Insightful Metabolite Identification Services of Biopharmaceuticals

Creative Proteomics Has Optimized Pre-treatments and Assays for Different Types of Vitamins

Elligo’s Rebecca Kush, Ph.D., Elected Chair of Vulcan Advisory Council

Elligo Health Research® today announced Chief Scientific Officer Rebecca Kush, Ph.D., will bring her expertise in clinical research, standards, and interoperability to her role as recently elected Chair of the Vulcan Advisory Council.

WCG IRB Expands Phase I Review Services, Partners With Dr. Vince Clinical Research

WCG today announced the expansion of its Phase I review services, providing purpose-built operations for Phase I investigators.

Dr. Vince Clinical Research Opens Industry-Leading Clinical Pharmacology Unit

Dr. Vince Clinical Research (DVCR) today announced the launch of its new, world-class clinical pharmacology unit and headquarters in Overland Park, Kansas.

University of Maryland School of Pharmacy Taps Komodo Health Platform To Power Real-World Evidence Research

Studies Will Examine Social Determinants of Health, Impact of Policy on Access, and Pandemic-Driven Disruptions to Healthcare Delivery

Quinten Health closes its financing round to advance disease modeling platforms and virtual twins in real-world

QUINTEN HEALTH has announced that it has closed its financing round to advance disease modeling platforms and virtual twins in real-world.

Dolomite Bio launches Nadia Go - An affordable microfluidic system for custom protocol development

Dolomite Bio has announced the launch of Nadia Go — an affordable microfluidic system for custom microfluidic and genomics research.

Tower to bring the temperature of pharmaceutical logistics to CPhI

Temperature-controlled containers that combine robust, reliable, and reusable benefits for the pharmaceutical supply chain will be showcased on the Tower Cold Chain stand, 91H66, zone ICSE, at this year’s CPhI worldwide, in Frankfurt.

MedPharm collaborates with Mosanna to develop new drug to tackle Metabolic Obstructive Sleep Apnea

Nuvera PURE Reports name 2022 “best-in-class” pharmaceutical companies in oncology, neurology and immunology

The Harley Street Medical Area (HSMA) Healthcare Conference unites world-leading institutions to discuss the future of life science innovation in London

Harley Street Medical Area has announced its Healthcare Conference is taking place on Wednesday 19th October 2022.

DAMAN enters ambitious European precision medicine healthcare project

Daman Digital (DAMAN), a digital healthcare partner based in Denmark, has announced its part in the ambitious European precision medicine healthcare project, SQUEEZE.

DISCOVERY LIFE SCIENCES INSTALLS THE LARGEST OLINK PLATFORM IN THE AMERICAS TO SUPPORT PROTEOMICS RESEARCH & BIOMARKER DEVELOPMENT AT SCALE

Discovery Life Sciences™ (Discovery), the Biospecimen and Biomarker Specialists™, has entered into an agreement with Olink Holding AB (publ) (Olink) and is installing the largest commercial platform of the Olink® technology in the Americas outside of Olink itself to become a leading global certified service provider for the Olink Proximity Extension Assay (PEA) technology, a unique anti-body based proteomic technology.

Curebase and Meru Health to Partner on Clinical Research for App-based Mental Health Treatment Program

Curebase, a company committed to democratizing access to clinical studies, today announced it is partnering with Meru Health on a three-year clinical trial to determine the effectiveness of the online mental healthcare provider’s 12-week treatment program for reducing depression among primary care patients.

BioIVT Launches GMP-grade VivoSTART Leukopaks for Cell and Gene Therapy Manufacturing

VivoSTART GMP-grade leukopaks complement BioIVT’s GMP-grade human AB serum, providing a complete solution for advanced therapy development.

Liposomes as Drug Delivery Vehicles

High-Quality Dexmedetomidine Hydrochloride (API) Meeting CP & EP Standards